VP
Vestal Point Capital, LP
NEW YORK NY · SEC CIK 0001974915
$4.28B2026Q2 reported value
68Positions
50.3%Top 10 weight · largest 8.1%
5 / 31New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
UTHR Added+$195.06M
BMRN Added+$140.19M
ABVX Added+$113.20M
NBIX Added+$106.18M
ZBH Added+$104.17M
2026Q2 top sells estimated at quarter-end value
RVMD Reduced-$360.51M
Apogee Therapeut Sold out-$92.59M
RGEN Reduced-$71.63M
SRRK Sold out-$65.11M
ARWR Reduced-$57.06M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc | $344.75M | 8.06% | 6,025,000 | 2,450,000 | 68.5% | $140.19M | Added |
| NBIX | Neurocrine Biosciences Inc | $316.85M | 7.40% | 1,880,000 | 630,000 | 50.4% | $106.18M | Added |
| ABVX | Abivax SA | $313.09M | 7.32% | 2,349,443 | 849,443 | 56.6% | $113.20M | Added |
| UTHR | United Therapeutics Corp | $235.70M | 5.51% | 435,000 | 360,000 | 480.0% | $195.06M | Added |
| ELVN | Enliven Therapeutics Inc | $203.00M | 4.74% | 4,000,000 | 750,000 | 23.1% | $38.06M | Added |
| NRIX | Nurix Therapeutics Inc | $195.29M | 4.56% | 8,050,000 | 1,550,000 | 23.8% | $37.60M | Added |
| BCAX | Bicara Therapeutics Inc | $155.87M | 3.64% | 5,250,000 | -175,000 | -3.2% | -$5.20M | Reduced |
| TSHA | Taysha Gene Therapies Inc | $132.22M | 3.09% | 19,415,000 | 1,415,000 | 7.9% | $9.64M | Added |
| ARWR | Arrowhead Pharmaceuticals Inc | $128.38M | 3.00% | 1,575,000 | -700,000 | -30.8% | -$57.06M | Reduced |
| ABT | Abbott Laboratories | $127.04M | 2.97% | 1,400,000 | 800,000 | 133.3% | $72.59M | Reappeared |
| ZBH | Zimmer Biomet Holdings Inc | $120.53M | 2.82% | 1,400,000 | 1,210,000 | 636.8% | $104.17M | Added |
| IRON | Disc Medicine Inc | $113.37M | 2.65% | 1,550,000 | 850,000 | 121.4% | $62.17M | Added |
| GLUE | Monte Rosa Therapeutics Inc | $111.32M | 2.60% | 4,600,000 | 996,535 | 27.7% | $24.12M | Added |
| PODD | Insulet Corp | $102.01M | 2.38% | 670,000 | 619,399 | 1,224.1% | $94.30M | Added |
| ASND | Ascendis Pharma A/S | $100.02M | 2.34% | 375,000 | 0 | 0.0% | — | Unchanged |
| AZN | AstraZeneca PLC | $85.33M | 1.99% | 450,000 | 350,000 | 350.0% | $66.37M | Added |
| SNY | Sanofi SA | $85.32M | 1.99% | 2,000,000 | 600,000 | 42.9% | $25.60M | Added |
| RVMD | Revolution Medicines Inc | $84.28M | 1.97% | 450,000 | -1,925,000 | -81.1% | -$360.51M | Reduced |
| BCRX | BioCryst Pharmaceuticals Inc | $83.00M | 1.94% | 8,300,000 | 1,275,000 | 18.1% | $12.75M | Added |
| DYN | Dyne Therapeutics Inc | $74.96M | 1.75% | 3,375,000 | -625,000 | -15.6% | -$13.88M | Reduced |
| NKTR | Nektar Therapeutics | $69.81M | 1.63% | 1,000,000 | 715,000 | 250.9% | $49.91M | Added |
| GMED | Globus Medical Inc | $67.16M | 1.57% | 850,000 | 239,480 | 39.2% | $18.92M | Added |
| TARS | Tarsus Pharmaceuticals Inc | $66.09M | 1.54% | 1,050,000 | 850,000 | 425.0% | $53.50M | Added |
| IMTX | Immatics NV | $62.55M | 1.46% | 6,175,000 | 0 | 0.0% | — | Unchanged |
| TRVI | Trevi Therapeutics Inc | $57.81M | 1.35% | 3,100,000 | 933,496 | 43.1% | $17.41M | Added |
| IMCR | Immunocore Holdings PLC | $57.15M | 1.34% | 1,800,000 | -966,868 | -34.9% | -$30.70M | Reduced |
| RGEN | Repligen Corp | $54.58M | 1.28% | 400,000 | -525,000 | -56.8% | -$71.63M | Reduced |
| BMY | Bristol-Myers Squibb Co | $46.10M | 1.08% | 800,000 | -200,000 | -20.0% | -$11.52M | Reduced |
| QURE | uniQure NV | $43.07M | 1.01% | 935,000 | 576,004 | 160.4% | $26.53M | Added |
| XENE | Xenon Pharmaceuticals Inc | $42.25M | 0.99% | 700,000 | 60,100 | 9.4% | $3.63M | Added |
| DRUG | Bright Minds Biosciences Inc | $38.26M | 0.89% | 545,000 | 52,681 | 10.7% | $3.70M | Added |
| MDGL | Madrigal Pharmaceuticals Inc | $34.90M | 0.82% | 65,000 | 33,532 | 106.6% | $18.01M | Added |
| ALC | Alcon AG | $33.55M | 0.78% | 500,000 | -300,000 | -37.5% | -$20.13M | Reduced |
| MYGN | Myriad Genetics Inc | $32.75M | 0.77% | 5,735,000 | 4,087,000 | 248.0% | $23.34M | Added |
| RAPP | Rapport Therapeutics Inc | $30.42M | 0.71% | 730,000 | -706,229 | -49.2% | -$29.43M | Reduced |
| CBIO | Crescent Biopharma Inc | $29.34M | 0.69% | 1,630,000 | 130,000 | 8.7% | $2.34M | Added |
| GEHC | GE HealthCare Technologies Inc | $28.80M | 0.67% | 450,000 | 200,000 | 80.0% | $12.80M | Added |
| INSM | Insmed Inc | $26.66M | 0.62% | 250,000 | 250,000 | — | $26.66M | New |
| VKTX | Viking Therapeutics Inc | $26.53M | 0.62% | 680,000 | -234,147 | -25.6% | -$9.13M | Reduced |
| BBNX | Beta Bionics Inc | $25.07M | 0.59% | 1,600,000 | -611,518 | -27.7% | -$9.58M | Reduced |
| REGN | Regeneron Pharmaceuticals Inc | $24.94M | 0.58% | 40,000 | 0 | 0.0% | — | Unchanged |
| SLDB | Solid Biosciences Inc | $21.58M | 0.50% | 2,160,000 | -2,840,000 | -56.8% | -$28.37M | Reduced |
| ANRO | Alto Neuroscience Inc | $20.72M | 0.48% | 785,000 | -1,279,075 | -62.0% | -$33.75M | Reduced |
| TRAX | First Tracks Biotherapeutics I | $20.38M | 0.48% | 1,013,000 | 1,013,000 | — | — | First reported |
| LXEO | Lexeo Therapeutics Inc | $20.11M | 0.47% | 4,320,000 | -155,000 | -3.5% | -$721,525 | Reduced |
| SVRA | Savara Inc | $16.76M | 0.39% | 2,720,000 | 119,948 | 4.6% | $738,880 | Added |
| DMRA | Damora Therapeutics Inc | $14.96M | 0.35% | 575,000 | -25,000 | -4.2% | -$650,250 | Reduced |
| SGP | SpyGlass Pharma Inc | $14.91M | 0.35% | 670,000 | 3,240 | 0.5% | $72,122 | Added |
| TECX | Tectonic Therapeutic Inc | $14.61M | 0.34% | 425,000 | 97,000 | 29.6% | $3.33M | Added |
| AVTX | Avalo Therapeutics Inc | $14.32M | 0.33% | 775,000 | 775,000 | — | $14.32M | New |
| EVMN | Evommune Inc | $13.29M | 0.31% | 1,000,000 | 1,000,000 | — | $13.29M | New |
| KLRA | Kailera Therapeutics Inc | $12.67M | 0.30% | 575,000 | 575,000 | — | — | First reported |
| AVR | Anteris Technologies Global Co | $9.95M | 0.23% | 1,010,000 | -134,780 | -11.8% | -$1.33M | Reduced |
| ZBIO | Zenas Biopharma Inc | $9.26M | 0.22% | 365,000 | 165,000 | 82.5% | $4.19M | Added |
| — | Voyager Therapeutics Inc | $9.19M | 0.21% | 2,625,000 | -377,936 | -12.6% | -$1.32M | Reduced |
| OKUR | OnKure Therapeutics Inc | $8.33M | 0.19% | 1,825,699 | -14,120 | -0.8% | -$64,387 | Reduced |
| SRZN | Surrozen Inc | $7.91M | 0.18% | 304,669 | -33,942 | -10.0% | -$880,795 | Reduced |
| MNPR | Monopar Therapeutics Inc | $7.01M | 0.16% | 75,727 | 10,309 | 15.8% | $954,510 | Added |
| ZURA | Zura Bio Ltd | $6.93M | 0.16% | 1,173,956 | 662,956 | 129.7% | $3.91M | Added |
| OLMA | Olema Pharmaceuticals Inc | $5.24M | 0.12% | 418,551 | -10,000 | -2.3% | -$125,100 | Reduced |
| PALI | Palisade Bio Inc | $5.22M | 0.12% | 2,500,000 | 0 | 0.0% | — | Unchanged |
| — | iBio Inc | $4.55M | 0.11% | 2,600,000 | 2,600,000 | — | $4.55M | New |
| SGMT | Sagimet Biosciences Inc | $4.14M | 0.10% | 535,452 | 535,452 | — | $4.14M | New |
| — | enGene Therapeutics Inc | $2.88M | 0.07% | 1,667,430 | -497,570 | -23.0% | -$860,796 | Reduced |
| RZLT | Rezolute Inc | $1.99M | 0.05% | 382,999 | -1,303,001 | -77.3% | -$6.78M | Reappeared |
| — | Nyxoah SA | $1.43M | 0.03% | 843,461 | -25,200 | -2.9% | -$42,588 | Reduced |
| TENX | Tenax Therapeutics Inc | $777,537 | 0.02% | 53,439 | 0 | 0.0% | — | Unchanged |
| — | Aprea Therapeutics Inc | $280,805 | 0.01% | 350,000 | 0 | 0.0% | — | Unchanged |
| — | Apogee Therapeutics Inc | $0 | 0.00% | 0 | -1,100,000 | -100.0% | -$92.59M | Sold out |
| SRRK | Scholar Rock Holding Corp | $0 | 0.00% | 0 | -1,324,422 | -100.0% | -$65.11M | Sold out |
| VERA | Vera Therapeutics Inc | $0 | 0.00% | 0 | -1,368,159 | -100.0% | -$55.04M | Sold out |
| — | Terns Pharmaceuticals Inc | $0 | 0.00% | 0 | -1,000,000 | -100.0% | -$52.72M | Sold out |
| BSX | Boston Scientific Corp | $0 | 0.00% | 0 | -800,000 | -100.0% | -$50.20M | Sold out |
| — | Nuvalent Inc | $0 | 0.00% | 0 | -481,715 | -100.0% | -$49.35M | Sold out |
| COGT | Cogent Biosciences Inc | $0 | 0.00% | 0 | -1,230,888 | -100.0% | -$47.38M | Sold out |
| CLDX | Celldex Therapeutics Inc | $0 | 0.00% | 0 | -1,224,165 | -100.0% | -$38.83M | Sold out |
| — | KalVista Pharmaceuticals Inc | $0 | 0.00% | 0 | -1,850,000 | -100.0% | -$37.24M | Sold out |
| PTGX | Protagonist Therapeutics Inc | $0 | 0.00% | 0 | -326,159 | -100.0% | -$34.38M | Sold out |
| DNLI | Denali Therapeutics Inc | $0 | 0.00% | 0 | -1,773,326 | -100.0% | -$34.05M | Sold out |
| WAT | Waters Corp | $0 | 0.00% | 0 | -100,000 | -100.0% | -$29.78M | Sold out |
| INSP | Inspire Medical Systems Inc | $0 | 0.00% | 0 | -539,269 | -100.0% | -$27.82M | Sold out |
| — | Soleno Therapeutics Inc | $0 | 0.00% | 0 | -730,000 | -100.0% | -$24.44M | Sold out |
| CYTK | Cytokinetics Inc | $0 | 0.00% | 0 | -300,000 | -100.0% | -$19.77M | Sold out |
| WST | West Pharmaceutical Services I | $0 | 0.00% | 0 | -75,000 | -100.0% | -$18.80M | Sold out |
| WGS | GeneDx Holdings Corp | $0 | 0.00% | 0 | -250,000 | -100.0% | -$16.05M | Sold out |
| AGIO | Agios Pharmaceuticals Inc | $0 | 0.00% | 0 | -450,000 | -100.0% | -$15.22M | Sold out |
| ARVN | Arvinas Inc | $0 | 0.00% | 0 | -905,465 | -100.0% | -$9.60M | Sold out |
| MPLT | MapLight Therapeutics Inc | $0 | 0.00% | 0 | -420,000 | -100.0% | -$8.54M | Sold out |
| FULC | Fulcrum Therapeutics Inc | $0 | 0.00% | 0 | -1,100,000 | -100.0% | -$8.44M | Sold out |
| CADL | Candel Therapeutics Inc | $0 | 0.00% | 0 | -1,125,000 | -100.0% | -$5.51M | Sold out |
| VCYT | Veracyte Inc | $0 | 0.00% | 0 | -130,687 | -100.0% | -$4.21M | Sold out |
| GERN | Geron Corp | $0 | 0.00% | 0 | -2,540,000 | -100.0% | -$3.78M | Sold out |
| NVCR | Novocure Ltd | $0 | 0.00% | 0 | -250,000 | -100.0% | -$2.73M | Sold out |
| URGN | UroGen Pharma Ltd | $0 | 0.00% | 0 | -139,079 | -100.0% | -$2.50M | Sold out |
| — | Passage Bio Inc | $0 | 0.00% | 0 | -305,000 | -100.0% | -$2.39M | Sold out |
| TYRA | Tyra Biosciences Inc | $0 | 0.00% | 0 | -54,000 | -100.0% | -$2.07M | Sold out |
| RGNX | REGENXBIO Inc | $0 | 0.00% | 0 | -108,525 | -100.0% | -$909,440 | Sold out |
| MGNX | MacroGenics Inc | $0 | 0.00% | 0 | -280,000 | -100.0% | -$809,200 | Sold out |
| ABSI | Absci Corp | $0 | 0.00% | 0 | -232,219 | -100.0% | -$696,657 | Sold out |